Literature DB >> 15648738

Optimization of conditions for clinical human hepatocyte infusion.

Robert A Fisher1, Dawen Bu, Melissa Thompson, Luke Wolfe, Joseph K Ritter.   

Abstract

Cytotoxicity and apoptosis are common problems in the isolation and storage of human hepatocytes. In vitro environments of hepatocytes during cell infusion may be critical to reducing cellular damage and enhancing cell viability. We examined the effects of donor liver histology (40-50% steatosis vs. normal), incubation time, temperature, and three solutions for infusion on banked primary human hepatocytes, by studying: trypan blue exclusion, AST release, LDH release, MTT assay, detection of DNA ladder, and a hepatocyte proliferation assay. In addition, the microstructure functions of the endoplasmic reticulum and mitochondria of the intact hepatocytes were determined by measuring correlates of UGT 1A1 and cytochrome P-450 3A (CYP3A4) activity. In general, hepatocyte viability decreased significantly within 60 min after thawing. Cells suspended in 5% dextrose lactated Ringers solution (D5LR) maintained greater cell viability. Hepatocytes from normal liver donors showed less AST and LDH enzyme leak in comparison with cells from fatty liver donors. Mild hypothermic temperature (32 degrees C) inhibited cellular damage that otherwise significantly increased at 60 min. Hepatocytes did not proliferate until 12 h from thaw, regardless of supernatant or conditions of suspension. CYP3A4 activity and a marker for UGT 1A1 activity in hepatocytes from normal donor livers were higher than those from steatotic donor livers. These findings suggest that hepatocytes suspended for infusion after isolation from normal liver donors have normal biological functions and less cellular damage/necrosis in contrast with those isolated from fatty liver donors. These damages are inhibited significantly by maintaining hepatocytes at a mild hypothermic temperature (32 degrees C). D5LR alone maintained the best cell viability for up to 60 min. Media of D5LR + adenosine and HMM were able to partially inhibit hepatocyte apoptosis in hepatocytes from steatotic livers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15648738     DOI: 10.3727/000000004783983576

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  4 in total

Review 1.  Human hepatocyte transplantation: current experience and future challenges.

Authors:  Anil Dhawan; Juliana Puppi; Robin D Hughes; Ragai R Mitry
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-04-06       Impact factor: 46.802

2.  Treatment of acute liver failure in mice by hepatocyte xenotransplantation.

Authors:  Tsuyoshi Yamamoto; Nalú Navarro-Alvarez; Alejandro Soto-Gutierrez; Takeshi Yuasa; Masaya Iwamuro; Yasuhiro Kubota; Masayuki Seita; Hironobu Kawamoto; Shahid M Javed; Eisaku Kondo; Hirofumi Noguchi; Satoru Kobayashi; Shuhei Nakaji; Naoya Kobayashi
Journal:  Cell Transplant       Date:  2010-06-23       Impact factor: 4.064

3.  Maintenance of Hepatic Functions in Primary Human Hepatocytes Cultured on Xeno-Free and Chemical Defined Human Recombinant Laminins.

Authors:  Masaaki Watanabe; Helen Zemack; Helene Johansson; Louise Hagbard; Carl Jorns; Meng Li; Ewa Ellis
Journal:  PLoS One       Date:  2016-09-06       Impact factor: 3.240

4.  Generation of fully functional hepatocyte-like organoids from human induced pluripotent stem cells mixed with Endothelial Cells.

Authors:  Giuseppe Pettinato; Sylvain Lehoux; Rajesh Ramanathan; Mohamed M Salem; Li-Xia He; Oluwatoyosi Muse; Robert Flaumenhaft; Melissa T Thompson; Emily A Rouse; Richard D Cummings; Xuejun Wen; Robert A Fisher
Journal:  Sci Rep       Date:  2019-06-20       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.